Regulator asks state bodies to limit scope of key cancer drug 0 21.05.2024 22:19 Economictimes.indiatimes.com India's drug regulator has asked manufacturers to stop marketing Olaparib tablets 100 mg and 150 mg for advanced ovarian cancer patients with 'gBRCA mutation'. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
